Membranous glomerulonephritis diagnostic study of choice: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
* The complete [[blood count]], [[urinalysis]], 24 hour [[Urine culture|urine]] collection should be performed when: | * The complete [[blood count]], [[urinalysis]], 24 hour [[Urine culture|urine]] collection should be performed when: | ||
** The patient presented with signs of proteinurea and hypertension | ** The patient presented with signs of [[proteinurea]] and [[hypertension]] | ||
** A positive test is detected in the patient | ** A positive test is detected in the patient | ||
* [[Biopsy|Renal biopsy]] is the gold standard test for the diagnosis of membranous glomerulonephritis | * [[Biopsy|Renal biopsy]] is the gold standard test for the diagnosis of membranous glomerulonephritis | ||
Revision as of 14:48, 19 July 2018
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis diagnostic study of choice |
|
FDA on Membranous glomerulonephritis diagnostic study of choice |
|
CDC on Membranous glomerulonephritis diagnostic study of choice |
|
Membranous glomerulonephritis diagnostic study of choice in the news |
|
Blogs on Membranous glomerulonephritis diagnostic study of choice |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]
Overview
The most efficient and sensitive test is ANA, ds-DNA antibodies specific test that is utilized for diagnosis of membranous glomerulonephritis. The gold standard test for the diagnosis of renal biopsy
Diagnostic Study of Choice
Gold standard/Study of choice:
- Renal biopsy is the gold standard test for the diagnosis of membranous glomerulonephritis[1]
- The complete blood count, urinalysis, 24 hour urine collection should be performed when:
- The patient presented with signs of proteinurea and hypertension
- A positive test is detected in the patient
- Renal biopsy is the gold standard test for the diagnosis of membranous glomerulonephritis
The diagnostic study of choice for membranous glomerulonephritis is:
Diagnostic Test:
- Renal biopsy is confirmatory of membranous glomerulonephritis[1]
Sequence of Diagnostic Studies
The urinalysis and comprehensive chemistry panel should be performed when:[2]
- The patient presented with signs of hypertension and proteinurea
- A positive ANA, anti dsDNA is detected in the patient, to confirm the diagnosis
Diagnostic Criteria
- There are no established criteria for the diagnosis of membranous glomerulonephritis
References
- ↑ 1.0 1.1 1.2 De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC (February 2017). "A Proposal for a Serology-Based Approach to Membranous Nephropathy". J. Am. Soc. Nephrol. 28 (2): 421–430. doi:10.1681/ASN.2016070776. PMC 5280030. PMID 27777266.
- ↑ Qin W, Beck LH, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z (June 2011). "Anti-phospholipase A2 receptor antibody in membranous nephropathy". J. Am. Soc. Nephrol. 22 (6): 1137–43. doi:10.1681/ASN.2010090967. PMC 3103733. PMID 21566055.